Elanco Animal Health Incorporated
ELAN News Today: Stay Updated with the Latest Elanco Animal Health Incorporated News in Real Time
Find ELAN news now at Meyka AI. Stay informed with the latest Elanco Animal Health Incorporated stocks updates, including price news, market analysis, and expert insights.
DW8.AX stock surges 2400% in after-hours trading on 27 Apr 2026
DW8.AX stock explodes 2400% in after-hours session with 54.5M volume. ASX beverage tech stock shows extreme volatility.
STLD Insiders Sell $1.9M in Steel Dynamics Stock April 27
STLD insiders sold 8,625 shares worth $1.9M on April 23 via coordinated insider transactions reported on Form 4.
EMAMIREAL.NS Surges 31.87% on April 27, 2026 – NSE Top Gainer
EMAMIREAL.NS stock jumps 31.87% to INR 99.92 on NSE. Real estate developer shows strong intraday momentum with 505,584 shares traded.
ADC Maintained at Neutral by Citigroup, April 2026
Citigroup maintained ADC at Neutral with price target raised to $82.50 from $77 on April 24, 2026.
WAF.SW stock plunges 16.3% in pre-market trading on 27 Apr 2026
Siltronic AG (WAF.SW) drops 16.3% to CHF 60.1 in pre-market session. Meyka AI rates stock C+ with Sell recommendation.
IQL.DE Stock Surges 125% in Pre-Market Trading on 27 Apr 2026
IQL.DE stock jumps 125% to €0.045 in pre-market session. iQ International AG shows explosive gains on XETRA exchange today.
LVL.CN Stock Surges 200% on CNQ: Level 14 Ventures Exploration Play
LVL.CN stock jumps 200% to C$0.60 on CNQ. Level 14 Ventures explores Green Mountain Property in BC with strong momentum.
Sun Pharmaceutical Industries to acquire Organon & Co. in $11.75B deal, Shares in focus
Sun Pharmaceutical Industries has made headlines with a massive global move. The company announced it will acquire Organon & Co. in a deal valued at $11.75 billion. This is one of the largest overseas acquisitions by an Indian pharma company. We see this deal as a turning point. It signals a shift from generics to…
HOLX Stock Holds $76.01 Ahead of April 30 Earnings Report
Hologic (HOLX) trades at $76.01 on NASDAQ ahead of Q2 2026 earnings on April 30. Analyst consensus holds at neutral with mixed technical signals.